Mannkind reported $159.21M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Adma Biologics ADMA:US $ 174.78M 3.43M
Biodelivery Sciences International BDSI:US $ 188.26M 7.8M
Chemocentryx CCXI:US $ 293.38M 23.75M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Dynavax Technologies DVAX:US $ 852.67M 268.76M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Immunogen IMGN:US $ 296.8M 22.41M
Insmed INSM:US $ 958.98M 79.21M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Kindred Biosciences KIN:US 79.08M 8K
Macrogenics MGNX:US $ 334.7M 32.3M
Mannkind MNKD:US $ 159.21M 20.7M
Minerva Neurosciences NERV:US $ 67.44M 7.79M
Novavax NVAX:US $ 2174.18M 180.81M
Novo Nordisk A Fs NVO:US $ 91213M 14067M
Peregrine Pharmaceuticals PPHM:US $ 200.78M 7.02M
Xencor XNCR:US $ 329.63M 151.34M